Eli Lilly To Pay $45M To SC In Zyprexa Off-Label Deal

Law360, New York (October 23, 2009, 6:40 PM EDT) -- In the latest of a series of state settlements over Zyprexa, Eli Lilly & Co. has agreed to pay $45 million to South Carolina to resolve allegations it improperly marketed the antipsychotic drug for off-label uses.

South Carolina Attorney General Henry McMaster said Friday that the deal was the largest monetary settlement any state in the U.S. had won from Lilly and the second-largest state settlement in South Carolina history.

“This is a victory for South Carolina's taxpayers who were forced to bear the financial costs...
To view the full article, register now.